Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Unaudited)

v3.26.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current Assets:    
Cash $ 278 $ 317
Restricted cash 380 741
Accounts receivable, net 804 673
Inventory, net 2,747 2,111
Prepaid expenses and other current assets 727 496
Total current assets 4,936 4,338
Goodwill 1,128 1,128
Intangibles, net 12,343 681
Property and equipment, net 1,879 1,955
Operating lease - right of use asset 3,267 2,015
Investment in NexGelRx 249 249
Other assets 95 95
Total assets 23,897 10,461
Current Liabilities:    
Accrued expenses and other current liabilities 673 462
Current portion of note payable 102 99
Partnership accrued advance 359 731
Current portion of finance lease liability 68 65
Current portion of operating lease liability 749 310
Derivative liability, at fair value 5,096
Total current liabilities 10,626 2,956
Operating lease liabilities, net of current portion 2,699 1,883
Financing lease liability, net of current portion 180 242
Convertible notes payable, net of debt discount 5,316
Notes payable, net of current portion 412 489
Total liabilities 19,233 5,570
Commitments and Contingencies (Note 16)
Stockholders’ Equity    
Preferred stock, par value $0.001 per share, 5,000,000 shares authorized, no shares issued and outstanding
Common stock, par value $0.001 per share, 25,000,000 shares authorized; 487,383 and 407,157 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively 1 1
Additional paid-in capital 30,797 25,454
Accumulated deficit (26,670) (20,995)
Total NexGel stockholders’ equity 4,128 4,460
Non-controlling interest in joint venture 536 431
Total stockholders’ equity 4,664 4,891
Total liabilities and stockholders’ equity 23,897 10,461
Nonrelated Party [Member]    
Current Liabilities:    
Accounts payable 3,129 723
Related Party [Member]    
Current Liabilities:    
Accounts payable $ 450 $ 566